April 26, 2012

Myrtle Potter & Company is retained by IMMUNE Pharmaceuticals

Myrtle Potter & Company is retained by IMMUNE Pharmaceuticals as Business Development Advisor for NanomAb Drug Conjugates Portfolio Israel, April 26, 2012 Myrtle Potter & Company is the advisory firm of Myrtle Potter, former COO and president of Commercial Operations at Genentech. As part of the collaboration, Myrtle Potter & Company has engaged Suzy Jones, who is […]

Keep Reading

January 30, 2012

Immune Pharmaceuticals Granted US $1 Million

Immune Pharmaceuticals Granted US $1 Million (NIS 3.8M) by the Office of the Chief Scientist in Israel January 30, 2012 “We are gratified that the Israeli Office of the Chief Scientist has selected Immune Pharmaceuticals to receive this award, which provides non-dilutive capital and external peer-reviewed validation demonstrating the therapeutic potential of Bertilimumab and Nanomabs,” said […]

Keep Reading

NEWS December 11, 2011

Here Come the NanomAbs

Bio Israel Life Sciences On-Line – December 11, 2011 at 7:56 am http://www.bioisrael.com/here-come-immunes-nanomabs   A new monoclonal antibody-based drug development company brings a fresh technological approach and ambitious business model to the Israeli biotech scene. Scientists for years have been looking for ways to enhance the specificity with which antibodies recognize antigens, their stability in […]

Keep Reading

EVENT May 10, 2010

Immune Pharmaceuticals to hold over forty one-on-one meetings at BIO 2012 in Chicago

NEW YORK, MAY 10, 2010 – Immune Pharmaceuticals, an emerging biopharmaceutical company, will participate in the BioBusiness Forum, the largest global partnering event, to be held as part of the 2010 BIO International Convention in Chicago. “BIO 2010 is the first partnering meeting for Immune Pharmaceuticals, and we expect to identify clinical stage in-licensing opportunities as […]

Keep Reading

EVENT April 15, 2010

Bioscience Corporate Showcase of the NYBA 2010 Annual Meeting

Immune Pharmaceuticals selected to present the Bioscience Corporate Showcase of the NYBA 2010 Annual Meeting   NEW YORK, APRIL 15, 2010 – Immune Pharmaceuticals, an emerging biopharmaceutical company and member of the New York Biotechnology Association (NYBA) has been selected alongside 14 other companies to present at the Bioscience Corporate Showcase during the NYBA 2010 Annual […]

Keep Reading